Key facts
| Price (PPV) | 20 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | acénocoumarol |
| Class | Antithrombotic agents |
| ATC code | B01AA07 |
| Manufacturer | SYNTHEMEDIC |
| Presentation | Boîte de 10 |
| Nature | Médicament |
| Hospital price | 12.50 MAD |
| Data collected on | 9/8/2026 |
Indications
- Cardiopathies emboligènes : prévention des complications thrombo-emboliques en rapport avec certains troubles du rythme auriculaire (fibrillations auriculaires, flutter, tachycardie atriale), certaines valvulopathies mitrales, les prothèses valvulaires. - Prévention des complications thrombo-emboliques des infarctus du myocarde compliqués : thrombus mural, dysfonction ventriculaire gauche sévère, dyskinésie emboligène, en relais de l’héparine. - Traitement des thromboses veineuses profondes et de l’embolie pulmonaire ainsi que la prévention de leur récidive, en relais de l’héparine.
Find an open pharmacy
On-call pharmacies near you
About Sintrom 4 mg
Sintrom 4 mg belongs to the antithrombotic agents therapeutic class. In Morocco, this drug is marketed by SYNTHEMEDIC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Sintrom 4 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Sintrom 4 mg
Answers to common questions from Moroccan patients about this drug.